Found 10 matching trials
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects PHASE3 This study is a randomized controlled, open-label, multicenter phase III cl...
Show More Learn More & Join Trial
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype PHASE3 The goal of this clinical trial is to evaluate the efficacy of investigator...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer. PHASE2 Phase II clinical trial of PD-L1 in combination with vinorelbine + cyclopho...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer PHASE3 The purpose of this study is to evaluate the efficacy and safety of pertuzu...
Show More Location
Aichi Cancer Center
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC PHASE1 This is an open-label, Single-arm, Phase I clinical study to evaluate the p...
Show More Location
The fifth medical center of the General Hospital of people's Liberation Army of China
Learn More & Join Trial
Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer PHASE3 This is a Phase III clinical trial for patients with a specific type of adv...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Learn More & Join Trial
Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab PHASE3 Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma PHASE3 Trial comparing standard treatment (chemotherapy) with pembrolizumab treatm...
Show More Location
Hospital Teresa Herrera
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) PHASE3 This phase III, multicenter, randomized, placebo-controlled, blinded trial ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC PHASE2 This is a randomized, open-label, multi-center, Phase II clinical study to ...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial